Featured
Advertisement
-
-
Immunologic prediction of long COVID
In addition to the acute phase of SARS-CoV-2 infection, a significant percentage of patients experience a prolonged illness with varying symptomatology. Longitudinal SARS-CoV-2 patient-centric immunologic, inflammatory and metabolic data collection has allowed the generation of a composite signature to predict recovery.
-
-
Trending - Altmetric
-
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
-
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children
-
Antibody responses to envelope glycoproteins in HIV-1 infection
-
Rebalancing TGFβ1/BMP signals in exhausted T cells unlocks responsiveness to immune checkpoint blockade therapy
Events
-
Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development
-
EMBO | EMBL Symposium: The human microbiome
-
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
-
Innate Immunity: From Innate Sensing to Adaptive Responses
-
EMBL Course: Advanced electron microscopy for cell biology